GWPH - GW Pharmaceuticals plc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.11B
Enterprise Value 32.68B
Trailing P/E N/A
Forward P/E 1-481.19
PEG Ratio (5 yr expected) 18.95
Price/Sales (ttm)14.11
Price/Book (mrq)4.34
Enterprise Value/Revenue 312.19
Enterprise Value/EBITDA 6-17.73

Trading Information

Stock Price History

Beta (3Y Monthly) 2.15
52-Week Change 3-15.69%
S&P500 52-Week Change 318.19%
52 Week High 3196.00
52 Week Low 390.14
50-Day Moving Average 3114.57
200-Day Moving Average 3144.00

Share Statistics

Avg Vol (3 month) 3764.8k
Avg Vol (10 day) 3578.06k
Shares Outstanding 530.91M
Float 30M
% Held by Insiders 10.62%
% Held by Institutions 181.95%
Shares Short (Nov. 15, 2019) 45.14M
Short Ratio (Nov. 15, 2019) 46.64
Short % of Float (Nov. 15, 2019) 4N/A
Short % of Shares Outstanding (Nov. 15, 2019) 416.62%
Shares Short (prior month Oct. 15, 2019) 45.06M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 31, 2018
Most Recent Quarter (mrq)Sep. 30, 2019

Profitability

Profit Margin -17.42%
Operating Margin (ttm)-73.34%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)220.13M
Revenue Per Share (ttm)6.78
Quarterly Revenue Growth (yoy)3,659.10%
Gross Profit (ttm)-19.8M
EBITDA -151.33M
Net Income Avi to Common (ttm)-38.35M
Diluted EPS (ttm)-1.26
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)554.68M
Total Cash Per Share (mrq)17.94
Total Debt (mrq)37.25M
Total Debt/Equity (mrq)5.18
Current Ratio (mrq)7.33
Book Value Per Share (mrq)23.28

Cash Flow Statement

Operating Cash Flow (ttm)-225.05M
Levered Free Cash Flow (ttm)N/A